Propanc Biopharma, Inc. (PPCB)
1.42
+0.05
(+3.65%)
USD |
NASDAQ |
Jun 09, 16:00
1.42
0.00 (0.00%)
After-Hours: 19:36
Propanc Biopharma EPS Diluted (Quarterly) : -7.09 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Mesoblast Ltd. | -- |
| Telix Pharmaceuticals Ltd. | -- |
| Amplia Therapeutics Ltd. | -- |
| Agenus, Inc. | 1.023 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.360M |
| Total Expenses (Quarterly) | 6.360M |
| Enterprise Value | 2.328M |
| Earnings Yield | -2.34K% |
| Normalized Earnings Yield | -2426.50 |